Such observations, together with evidence reporting a correlation between high levels of MAGEC2 and tumor metastasis in primary melanoma and breast cancer cells [89,90], indicate this protein as a promising target for treatment of tumor metastasis. The gene discussed is MAGEC2; the disease is neoplasm.